Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
33465 | 91 | 38.0 | 95% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
3281 | 1413 | TARDIGRADA//EUTARDIGRADA//HETEROTARDIGRADA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | IEX 1 | Author keyword | 34 | 79% | 24% | 22 |
2 | IMMEDIATE EARLY GENE X 1 IEX 1 | Author keyword | 1 | 100% | 2% | 2 |
3 | IMMEDIATE EARLY RESPONSE GENE X 1 | Author keyword | 1 | 100% | 2% | 2 |
4 | OSTEOCARCINOMA | Address | 1 | 100% | 2% | 2 |
5 | EARLY RESPONSE GENE | Author keyword | 1 | 17% | 4% | 4 |
6 | IER3 | Author keyword | 1 | 50% | 1% | 1 |
7 | MEDANESTHESIA CRIT CARE | Address | 1 | 50% | 1% | 1 |
8 | SECT PULM CRIT CARE MED ALLERGY SLEEP | Address | 1 | 50% | 1% | 1 |
9 | MITOQUINONE | Author keyword | 1 | 25% | 2% | 2 |
10 | COCHIN HEMATOL | Address | 0 | 33% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | IEX 1 | 34 | 79% | 24% | 22 | Search IEX+1 | Search IEX+1 |
2 | IMMEDIATE EARLY GENE X 1 IEX 1 | 1 | 100% | 2% | 2 | Search IMMEDIATE+EARLY+GENE+X+1+IEX+1 | Search IMMEDIATE+EARLY+GENE+X+1+IEX+1 |
3 | IMMEDIATE EARLY RESPONSE GENE X 1 | 1 | 100% | 2% | 2 | Search IMMEDIATE+EARLY+RESPONSE+GENE+X+1 | Search IMMEDIATE+EARLY+RESPONSE+GENE+X+1 |
4 | EARLY RESPONSE GENE | 1 | 17% | 4% | 4 | Search EARLY+RESPONSE+GENE | Search EARLY+RESPONSE+GENE |
5 | IER3 | 1 | 50% | 1% | 1 | Search IER3 | Search IER3 |
6 | MITOQUINONE | 1 | 25% | 2% | 2 | Search MITOQUINONE | Search MITOQUINONE |
7 | DIFFERENTIATION AND APOPTOSIS | 0 | 33% | 1% | 1 | Search DIFFERENTIATION+AND+APOPTOSIS | Search DIFFERENTIATION+AND+APOPTOSIS |
8 | IEX | 0 | 25% | 1% | 1 | Search IEX | Search IEX |
9 | G ALPHAI2 | 0 | 13% | 1% | 1 | Search G+ALPHAI2 | Search G+ALPHAI2 |
10 | HYDROXYTAMOXIFEN | 0 | 11% | 1% | 1 | Search HYDROXYTAMOXIFEN | Search HYDROXYTAMOXIFEN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EARLY RESPONSE GENE | 34 | 65% | 36% | 33 |
2 | IEX 1 EXPRESSION | 18 | 89% | 9% | 8 |
3 | IEX 1 | 15 | 68% | 14% | 13 |
4 | X 1 IEX 1 | 6 | 100% | 4% | 4 |
5 | P22 PRG1 | 1 | 100% | 2% | 2 |
6 | PRG1 | 1 | 100% | 2% | 2 |
7 | B RELA | 1 | 50% | 1% | 1 |
8 | MECHANICALLY INDUCED GENES | 1 | 50% | 1% | 1 |
9 | PLASMACYTOID DIFFERENTIATION | 1 | 50% | 1% | 1 |
10 | F1FO ATPASE INHIBITOR | 1 | 25% | 2% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Role of the immediate early response 3 (IER3) gene in cellular stress response, inflammation and tumorigenesis | 2011 | 31 | 62 | 73% |
Immediate early response gene X-1, a potential prognostic biomarker in cancers | 2013 | 4 | 75 | 36% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | OSTEOCARCINOMA | 1 | 100% | 2.2% | 2 |
2 | MEDANESTHESIA CRIT CARE | 1 | 50% | 1.1% | 1 |
3 | SECT PULM CRIT CARE MED ALLERGY SLEEP | 1 | 50% | 1.1% | 1 |
4 | COCHIN HEMATOL | 0 | 33% | 1.1% | 1 |
5 | INSERM U1009 | 0 | 14% | 1.1% | 1 |
6 | VASC INTERVENT RADIOL TRANSLAT | 0 | 13% | 1.1% | 1 |
7 | MOL GASTROENTEROL HEPATOL 1 | 0 | 100% | 1.1% | 1 |
8 | SEGAL CANC SMBD | 0 | 100% | 1.1% | 1 |
9 | SHANGHAI DIGEST SURGRUIJIN HOSP SURG | 0 | 100% | 1.1% | 1 |
10 | SHENZHE BIOTECH HLTH | 0 | 100% | 1.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000126609 | CANC VACCINE DEV//INNOVAT CANC THER Y//PERSONALIZED PEPTIDE VACCINE |
2 | 0.0000084338 | P8//NUPR1//COM 1 |
3 | 0.0000082902 | GENETIC RADIOTHERAPY//GENE RADIOTHERAPY//PEDIAT MICROBIOL IMMUNOL RADIOL |
4 | 0.0000068995 | CDK2AP1//DOC 1//P12CDK2 AP1 |
5 | 0.0000064432 | I KAPPA B//IKK//C REL |
6 | 0.0000061995 | PERSISTENT MULLERIAN DUCT SYNDROME//TRANSVERSE TESTICULAR ECTOPIA//UNITE RECH ENDOCRINOL DEV |
7 | 0.0000051433 | CIP2A//PROTEIN PHOSPHATASE 2A//PP2A |
8 | 0.0000048311 | IN VITRO CARCINOGENESIS CELLULAR CHEMOTHER//VITRO CARCINOGENESIS CELLULAR CHEMOTHER Y//TARGET BASED DRUG |
9 | 0.0000045464 | GI ALPHA PROTEINS//GI ALPHA PROTEIN//GQALPHA PROTEIN |
10 | 0.0000044985 | RESPIRATION PHOSPHORYLATION COUPLING//CLIN PHARMACOL CLIN NEUROSCI//MOUSE PLATELETS |